Physician profile
Seth C Gamradt
NPI 1366642753
$566,554.69
in general payments reported to CMS, 2019-2025
6 companies · $142K in 2025
The $142K reported for 2025 was more than what 98% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,906 · 2020: $34K · 2021: $84K · 2022: $99K · 2023: $105K · 2024: $99K · 2025: $142K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $183K · Consulting Fee: $85K · Education: $61K · Travel and Lodging: $17K · Food and Beverage: $1,858.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $183,326.86 |
| Consulting Fee | $84,500.00 |
| Education | $60,750.00 |
| Travel and Lodging | $16,676.19 |
| Food and Beverage | $1,858.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $524,568.36 | 2020-2025 | Comprehensive Glenoid, Comprehensive, Comprehensive Shoulder System |
| Exactech, INC. | $41,012.56 | 2019-2023 | |
| Arthrex, INC. | $388.33 | 2020-2021 | |
| Stryker Corporation | $293.85 | 2021-2023 | Viaflow, Inbone, Augment Injectable |
| Smith+Nephew, INC. | $174.75 | 2019-2021 | |
| Micromed INC | $116.84 | 2020-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Gamradt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.